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Abstract,  Different mouse muscle cell lines were 
found to express distinct patterns of myosin heavy 
chain (MHC) isoforms, MyoD1, and myogenin, but 
there appeared to be no correlation between the pat- 
tern of MHC expression and the patterns of MyoD1 
and myogenin expression.  Myogenic cell lines were 
generated from unconverted C3H10T1/2  cells by 
5-azacytidine treatment  (Aza cell lines) and by stable 
transfection with MyoD1 (TD cell lines) or myogenin 
(TG cell lines).  Myogenic differentiation of the newly 
generated cell lines was compared to that of the C2C12 
and BC3H-1 cell lines.  Immunoblot analysis showed 
that differentiated cells of each line expressed the em- 
bryonic and slow skeletal/B-cardiac MHC isoforms 
though slow MHC was expressed at a much lower, 
barely detectable level in BC3H-1 cells.  Differentiated 
cells of each line except BC3H-1 also expressed an ad- 
ditional MHC(s) that was probably the perinatal  MHC 
isoform.  Myogenin mRNA was expressed by every 
cell line, and,  with the exception of BC3H-1  (cf., 
Davis, R. L., H. Weintraub,  and A.  B. Lassar.  1987. 
Cell.  51:987-1000),  MyoDl mRNA was expressed by 
every cell line.  To determine if MyoD1 expression 
would alter the differentiation of BC3H-1 cells, cell 
lines (termed BD) were generated by transfecting 
BC3H-1 cells with MyoD1 under control of the B-actin 
promoter.  The MyoD1 protein expressed in BD cells 
was correctly localized in the nucleus,  and,  unlike the 
parental BC3H-1 cell line that formed differentiated 
MHC-expressing cells, which were predominately 
mononucleated, BD cell lines formed long,  mul- 
tinucleated myotubes (cf., Brennan,  T. J., D.  G.  Ed- 
mondson,  and E.  N.  Olson.  1990.  J.  Cell.  Biol. 
110:929-938).  Despite the differences in morphology 
and MyoD1 expression, BD myotubes and the parent 
BC3H-1 cells expressed the same pattern of sarco- 
meric MHCs. 
V 
ERTEBRATE muscle contains a heterogeneous popu- 
lation of fast and slow skeletal muscle fibers that have 
different  biochemical  phenotypes  and  contraction 
rates. The contraction rate of a striated muscle cell is largely 
determined by the ATPase activity of the myosin heavy chain 
(MHC)  ~  isoform or isoforms expressed in the cell (Schwartz 
et al., 1981; Reiser et al., 1985; Sweeney et al., 1988). MHC 
isoform expression is, therefore,  both the molecular deter- 
minant of and a marker for skeletal muscle fiber diversifica- 
tion during  development (Bandman,  1985; Whalen,  1985; 
Stockdale and Miller,  1987). In the rat and mouse, multiple 
striated muscle MHC isoforms have been identified,  and the 
expression  of each of these MHCs is regulated  so that each 
isoform is expressed only in certain striated muscle cells and 
at certain stages of development (Whalen et al., 1981; Izumo 
et al., 1985; Emerson and Bernstein,  1987; Naruzawa et al., 
1987; Weydert et al.,  1987; B~ir and Pette,  1988; Vivarelli 
et al.,  1988;  Schiaflino  et al.,  1988, 1989;  Harris et al., 
1989). 
1. Abbreviations usedin thispaper: MHC, myosin heavy chain; P2, postna- 
tal day 2. 
Observations  in vivo and in vitro suggest that MHC iso- 
form expression  is regulated  by multiple cellular processes 
that  can occur in either myoblasts  or myotubes during  the 
multi-stage  process  of  muscle  fiber  formation.  Though 
MHC isoform expression  is regulated  by extrinsic  factors 
such as thyroid hormone levels and the activity pattern of the 
innervating motor neuron (Jolesz and Srtter, 1981; Pette and 
Vrbov~i, 1985; Izumo et al., 1986), factors intrinsic to myo- 
genic cells also influence  the MHC phenotype of muscle 
fibers (Kelly, 1983; Miller and Stockdale,  1987; Cossu and 
Molinaro,  1987),  For  example,  sequential  transitions  or 
modulations  of MHC isoform expression occur within avian 
and mammalian myotubes in culture in the absence of inner- 
vation (Cerny and Bandman,  1986; Silberstein  et al., 1986; 
Weydert et al., 1987; Miller and Stockdale,  1989). Addition- 
ally, multiple types of avian and mammalian  myoblasts have 
been shown to appear sequentially at different stages of mus- 
cle development,  and multiple types of avian myoblasts have 
been found that are intrinsically  committed to form distinct 
types of fast and slow MHC-expressing myotubes (White et 
al., 1975; Rutz and Hauschka, 1982; Miller and Stockdale, 
1986a,  1986b;  Cossu and Molinaro,  1987; Schafer et al., 
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Stockdale,  1989). 
Recently, the molecular analysis of myogenesis has ad- 
vanced with the identification of several myogenic regulatory 
factors including  MyoD1, myd, myogenin,  Myf-5, MRF4, 
and the ski oncogene that can convert some types of nonmyo- 
genie cells into myoblasts (Lassar et al., 1986; Davis et al., 
1987; Pinney et al., 1988; Braun et al., 1989a; Colmenares 
and Stavnezer, 1989; Edmondson and Olson,  1989; Rhodes 
and Konieczny, 1989; Wright et al., 1989; Miner and Wold, 
1990). MyoD1, myogenin, Myf-5, and MRF4 form a family 
of homologous,  DNA-binding proteins that appear to regu- 
late expression  of each other and of other muscle-specific 
proteins (Braun et al., 1989a; Lin et al., 1989; Thayer et al., 
1989). During mouse embryogenesis, myogenin and MyoD1 
mRNAs are expressed in different patterns in the developing 
somites  and limbs  (Sassoon  et al.,  1989). These findings 
raised the possibility that different patterns of MHC isoform 
expression might result from different patterns of expression 
of the individual MyoDl-like proteins.  To begin to test this 
possibility, the expression  of MHC isoforms,  MyoD1, and 
myogenin  has  been  analyzed  in  the  differentiated  cells 
formed by previously described and newly generated mouse 
myogenic cell lines. 
Materials and Methods 
Cell Lines and Culture 
Table I lists the myogenic cell lines used in this study. C3H1Olrl/2 clone 8 
(Reznikoff et al.,  1973), BC3H-1 (Schubert et al.,  1974), and C2Cj2 (Yaffe 
and Saxel,  1977; Blan et al., 1985) cells were obtained from the American 
Type Culture Collection (Rockville, MD). The Aza2 myogenic cell line was 
generated in this laboratory by expansion of a myogenic clone resulting 
from 5-azacytidine  conversion of 10I"1/2 cells (Taylor and Jones,  1979; 
Konieczny  and Emerson,  1985).  Myogenic  cell lines TD33,  TD38,  and 
TD45 were obtained from independent experiments in which ,'ol(f 1011/2 
cells were co-transfected  with 0.2 #g pSV2neo and 10/~g pEMClls using 
cationic liposome-mediated  transfection (Lipofectin  reagent,  Bethesda Re- 
search  Laboratories,  Gaithersburg,  MD).  MYOD1  is  expressed  from  a 
Moloney sarcoma virus LTR promoter on pEMCIls (Davis et al.,  1987). 
Myogenic colonies resistant to 500/zg/ml of active G-418 were selected, 
recloned twice,  and expanded.  The TG1  cell  line was obtained by co- 
transfection of 10TI/2 ceils with 0.2/~g pSV2neo and 10 #g pEMSV-mouse 
myogenin  (pEMSV-Myo8;  Edmondson and Olson,  1989).  ,~103 G-418- 
resistant colonies were obtained per 1/~g pSV2neo. In control experiments, 
no myogenic colonies were found among several hundred G-418-resistant 
colonies resulting from transfection of 10"I"1/2  cells with pSV2neo alone. Af- 
ter several unsuccessful attempts to express MyoD1 in BC3H-1 cells by co- 
transfection with pEMClls and pSV2neo,  the BDI, BD2, and BD10 lines 
were  obtained in independent experiments by transfecting  BC3H-I  cells 
with 0.2/~g of pEM340 (a gift of Dr. C. P. Emerson, Department of Biology, 
University of Virginia), a plasmid which contains MyoD1 eDNA expressed 
under control of the/~-actin promoter and the neo  r gene for selection. 
To eliminate effects due to different culture conditions,  all cell lines were 
grown in the same manner (Miller,  1984). Dividing myoblasts that did not 
express  striated muscle MHCs were maintained at <75 % confluence in a 
medium consisting of BME supplemented with 15 % FCS (Gibco Laborato- 
ries, Grand Island, NY), I mM glutamine, and 100 U/ml penicillin (growth 
medium).  To induce myogenic  differentiation,  nearly confluent  cultures 
were switched to a low mitogen medium consisting of DME supplemented 
with 10% horse serum (Hazleton Systems, Inc., Aberdeen, MD), 1% FCS, 
glutamine, and penicillin (differentiation medium). Media were used at 0.2 
ml/cm2; dishes were gelatin-coated;  and cultures were incubated in a hu- 
midified atmosphere of 95% air,  5% C(h at 370C. FCS was selected  for 
ability to support clonal growth of primary adult human myoblasts (Levet 
al., 1987) and horse serum was selected for ability to support muscle colony 
formation from embryonic day  19 mouse muscle cells (Hauschka et al., 
1979). 
Monoclonal A n tibodies 
The preparation and properties of mAbs $46, $58, F47, and F59 have been 
described (Crow and Stockdale,  1984; Miller et al.,  1985; Stockdale  and 
Miller,  1987; Evans et al., 1988; Miller and Stockdale,  1989; Miller et al., 
1989). An additional mAb, mAh $22, was prepared similarly using chicken 
slow MHCs as immunogens.  The reactivities  of these mAbs with mouse 
MHC isoforms were determined and are shown in Table II. R11D10, a mAb 
that reacts specifically and with high affinity with human/~-cardiac MHC 
(Khaw et al.,  1984),  was also found to be specific for the slow skeletal/ 
/~-cardiac MHC of the mouse (Table II). Three additional slow MHC-specific 
mAhs, NOQT.5.4D, NA7, and NAB, were also used (Narusawa et al., 1987; 
Harris et al., 1989; Bandman et al., 1990). All experiments used either 1:10 
dilutions of hybridoma supernatants (mAbs $22, $46, $58, F47, F59, and 
NOQ7.5.4D), 500 ng/ml of purified antibody (mAb RIlDI0); or 1:500 dilu- 
tions of ascites fluid (mAbs NA7 and NAB). An adult mouse MHC isoform 
termed IIX or liD has been described (B~ and Pette,  1988; Schiaflino et 
al.,  1989); mAbs $58, $46, $22, and RllD10 did not react with this MHC 
because the electrophoretic  mobility of the slow MHC that reacted with 
these mAhs was more rapid than that reported for IIX/D MHC (Schiaflino 
et al.,  1989). Both rnAbs F47 and F59 reacted with the IIX/D MHC (not 
shown).  The mouse embryonic  MHC isoform expressed  in El4 limbs and 
Table L Mouse Muscle Cell Lines 
Differentiated 
Cell line  Origin  cell type  Differentiation index* 
Aza2  5-azacytidine-converted lOT1~2  Mononucleated myocytes and  10-30% 
multinucleated myotubes 
Brain tumor  Mononucleated myocytesll  20-50% 
MyoDl-transfected BC3H-1  20-50% 
Adult leg  30-50% 
MyoD 1-transfected 10TI/2  10-30% 
Myogenin-transfected 10T1/2  5-30% 
BC3H-I:t 
BDI,  BD2, 
and BD10 
C2Ct2~' 
TD33,  TD38, 
and TD45 
TG1 
Multinucleated myotubesl 
Multinucleated myotubes'l 
Multinucleated myotubesl 
Mononucleated myocytes and 
multinucleated myotubes 
* The differentiation index was the percentage of all nuclei in a culture that were contained within MHC-expressing (i.e.,, F59-reactive) myocytes and myotubes 
after 7 d in differentiation medium. Approximate ranges are given to reflect observations from different experiments with cell lines at different passage numbers. 
¢ Schubert et al.,  1974. 
§ Yaffe and Saxel,  1977; Blau et al.,  1985. 
[[ In addition to the predominant mononucleated myocytes, a small number of multinucleated myotubes, containing <10%  of the nuclei found in differentiated 
cells, were formed by BC3H-1 cells. 
¶ In addition to the predominant multinucleated myotubes, a small number of the differentiated cells formed by these cell lines were mononucleated myocytes. 
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Reaction of mAb with MHC isoform* 
Monoclonal 
antibody  Embryonic  Perinatal  Type IIA  Type IIB  or-cardiac  Slow//5--eardiac 
$22  .....  + + 
$46  .....  +  + 
$58  .....  + + 
RllD10  .....  +++ 
F47  -  +++  +++  +++  -  - 
F59  +++  +++  +++  +++  +++  +++ 
* MHCs from whole muscles or cultures were subjected to SDS-PAGE in 5% gels, transferred to immunoblots,  and tested for reaction with each mAb. Individual 
MHC isoforms were distinguished  by electrophoretic  mobility and expression patterns in animals of different ages and in different muscles or cell cultures  (cf., 
Schiaffino et al.,  1988,  1989). The embryonic MHC was from BC3H-1 cultures and El4 limb muscle;  pednatal MHC was from C2C1: cultures  (Silberstein  et 
al., 1986) and P'2 limb muscle; Type HA MHC was from the adult diaphragm and adult soleas; Type 1/13 MHC was from adult quadriceps;  a-cardiac MHC was 
from P'2 ventricle and adult ventricle;  and slow skeletal/B-cardiac MHC was from P2 ventricle, adult diaphragm,  and adult soleus. Equal amounts of myosin from 
each sample were analyzed and the intensity of mAb reaction with each sample was compared using the antibody concentrations or hybridoma supernatant dilutions 
stated in Materials  and Methods; + + +, strong reaction;  + +, moderate  reaction;  +, weak reaction;  -,  no detectable  reaction. 
BC3H-1  myocytes did not react with mAb F47 (Table II, Fig. 5), though 
earlier work (Miller et al.,  1989)  suggested that mAb F47 did react very 
weakly with the rat embryonic MHC isoform. This difference may either 
be due to the species difference or to a small amount of perinatal MHC ex- 
pression in the embryonic rat limb muscle (Harris et al., 1989).  The differ- 
ences in electrophoretic mobilities among the mouse MHC isoforms mir- 
rored those found for rat MHCs by Schiaflino et al. (1988,  1989).  None of 
the mAbs listed in Table I reacted with smooth muscle or nonsarcomeric 
cytoplasmic MHCs (Evans et al., 1988; Miller et al., 1989; and our unpub- 
lished observations). 
Immunocytochemistry and Electrophoresis 
Cultures were fixed for 5 rain in 100%  ethanol at room temperature, in- 
cubated for 1 h at room temperature with mAbs diluted in PBS containing 
2%  horse serum and 2%  BSA; and mAb binding was visualized with a 
horseradish peroxidase-linked system using diaminobenzidine as substrate 
(Vectastain ABC kit, Vector Laboratories Inc., Burlingame, CA). For dou- 
ble  immunofluorescence, a  modification of the  method of Wessel and 
McClay (1986)  was used (Miller and Stockdale, 1989).  Samples were in- 
cubated with the first mAb (F47 or RI1D10) followed by sequential incuba- 
tions with (a) a saturating amount (100 tzg/rni) of the monovalent fab frag- 
ment of fluorescein-conjugated goat anti-mouse IgG (Cappel Laboratories, 
Malvern, PA);  (b) the second mAb (F59);  and (c)  10/zg/ml rhodamine- 
conjugated goat anti-mouse IgG. Control experiments, using mAbs that did 
not react with muscle, showed that the observed fluorescence was due to 
mAb binding to MHC. Immunofluorescence analysis of MyoD1 expression 
was performed with rabbit anti-MyoD1 serum (Tapscott et al.,  1988). 
The differentiation index was calculated as the percentage of nuclei in 
a  culture  that  were  contained  in  differentiated  cells  (including  both 
mononucleated myocytes  and  multinucleated myotubes).  Cultures  were 
fixed, differentiated cells were identified by irnmunotiuorescent staining 
with mAb F59,  and  nuclei were identified by fluorescent staining with 
Hoechst 33258.  Numbers of nuclei in differentiated and undifferentiated 
cells were then determined from observations of at least five microscope 
fields. The differentiation index was used to allow comparison of cell lines 
that formed mononucleated MHC-expressing myocytes (e.g., BC3H-1) with 
the differentiation  of cell lines that formed multinucleated MHC-expressing 
myotubes (e.g., C2C12). 
Myosin from  cultures or tissue  samples was prepared as previously 
(Evans et al., 1988).  MHC isoforms were separated by SDS-PAGE in 5% 
gels,  and  transferred to  nitrocellulose (Rushbrook and  Stracher,  1979; 
Miller et al., 1985; Miller and Stockdale, 1986a).  The nitrocellulose trans- 
fers were incubated for 1-2 h at room temperature with mAbs diluted in PBS 
containing 2% nonfat powdered dry milk, and mAb binding was visualized 
using an alkaline phosphatase-linked system (Vectastain ABC-AP kit, Vec- 
tor Laboratories Inc.). One-dimensional peptide maps of protease-digested 
MHCs were obtained by modifying the procedures of Cleveland (1983) and 
Bandman (1985).  MHCs were subjected to SDS-PAGE in 5% gels, briefly 
stained with Coomassie blue, and the regions of the gel containing MHC 
were excised. The gel pieces were equilibrated in sample buffer, inserted 
into sample wells of a 15 % gel, and partially digested with 250 ng of  Staphy- 
lococcus aureus V8 protease as described (Schafer et al., 1987). After elec- 
trophoresis, the partial proteolytic fragments were transferred to nitrocellu- 
lose,  incubated  with  mAb,  and  mAb binding  was  visualized with the 
alkaline phosphatase-linked system. 
mRNA Analysis 
Total RNA was prepared by a modification of the method of Cbeley and An- 
derson (1984).  Solubilization buffer consisting of 7.6 M guanidine hydro- 
chloride and 0.1 M potassium acetate (pH 5) was added to PBS-washed cul- 
tures at 1 rnl/6-cm dish; solubilized cells were collected by scraping; DNA 
was sheared by vortexing for 30 s; and the homogenates were centrifuged 
at 13,000 rpm for 5 rain. Supernatants were collected, mixed with 0.6 voi 
100% ethanol, incubated at least 16 h at -20°C, and RNA pellets were col- 
lected by contrifugation at 13,000  rpm for 5 rain. After electrophoresis in 
1% agarose-formaldehyde gels, the RNAs were transferred and UV cross- 
linked to a Nytran nylon membrane (Schleicher &  Schuell, Inc., Keane, 
NH). MyoDl and myogenin eDNA probes were prep-areal by random primer 
labeling with [32P]dCTP  (Feinberg and Vogelstein, 1983).  Eco RI diges- 
tion of pEMClls was used to yield the •l.8-kb  eDNA fragment encoding 
MyoD1 (Davis et al., 1987) and partial Eco RI digestion of pEMSV-myo- 
genin was used to yield the ,~l.6-kb eDNA fragment encoding mouse myo- 
genin (Edmondson and Olson, 1989); both fragments were purified, and 50 
ng of each fragment were used as templates in parallel labeling reactions. 
Specific activities of the MyoD1  and myogenin probes differed by <20%. 
To compare relative amounts of MyoD1 and myogenin mRNAs, RNA sam- 
ples were quantitated by OD260; 10/.tg of each sample were applied to 
duplicate wells of a single gel containing two rows of sample wells; elec- 
trophoresis and transfer of the gel were performed; and the transfers were 
cut to provide duplicates. Hybridization with the appropriate probe was in 
50% formamide, 5 x  SSC, 1 x  PE (PE =  50mM Tris, pH 7.5, 0.1% sodium 
pyrophosphate, 1%  SDS, 0.2% polyvinylpyrrolidone, 0.2%  ficoll, 5 mM 
EDTA, 0.2% BSA), 100 t~g/ml salmon sperm DNA at 50°C for 16 h; and 
membranes were washed with 0.1  x  SSC, 0.1%  SDS at 65°C. 
Results 
Differentiation of  Mouse Muscle Cell Lines 
To determine whether different types of mouse muscle cell 
lines expressed distinct patterns ofMHCs, MyoD1, and myo- 
genin, the differentiation patterns of five newly generated 
and two previously isolated myogenic cell lines were com- 
pared. Table I lists characteristics of these lines. C3H mice 
were the initial sources of the previously isolated C2C~2 and 
BC3H-1  myogenic lines and of the C3H10T1/2  cells from 
which the new myogenic cell lines were generated (Reznikoff 
et al.,  1973;  Schubert et al.,  1974;  Yaffe and Saxel,  1977; 
Blau et al.,  1985).  Myogenic conversion of 10T1/2 cells by 
5-azacytidine treatment  (Aza2  line),  MyoD1  transfection 
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entiated  cells  formed by mouse 
muscle cell lines. Aza2, BC3H-1, 
C2C12, TD33, and TG1 cells were 
cultured in growth medium until 
near confluence  and then incubated 
for a further 7 d in differentiation 
medium.  MHC expressing cells 
were  identified by immunocyto- 
chemical staining with mAh F59 
using  a  horseradish  peroxidase- 
conjugated system for detection. 
Undifferentiated  cells  that  filled 
the spaces between differentiated 
cells are not seen well with this 
bright  field image. Arrows indi- 
cate mononucleated  myocytes in 
Aza2, C2C12, TD33, and TG1 cul- 
tures.  Bar,  100 ttm. 
(TD33,  TD38,  and TD45 lines),  or myogenin transfection 
(TGI line) (Taylor and Jones,  1979; Davis et al.,  1987;  Ed- 
mondson and Olson,  1989)  was used to generate the new 
myogenic cell lines. When maintained below confluence in 
high mitogen growth medium (15% FCS), cells of each line 
replicated as  undifferentiated  myoblasts that  did  not react 
with mAb F59.  Because mAb F59 reacted with all mouse 
sarcomeric MHC isoforms (Table I), replicating myoblasts 
did  not  appear to  accumulate  sarcomeric MHC  proteins. 
Upon switching to low mitogen differentiation medium (10 % 
horse serum,  1% FCS),  cells of each line formed differen- 
tiated cells that reacted with mAb F59 (Fig.  1). 
The morphology of  the differentiated cells and the percent- 
age of nuclei found in differentiated cells (the differentiation 
index) varied among the cell lines (Fig.  1, Table I). Most of 
the cell lines  formed multinucleated  myotubes as the pre- 
dominant type of MHC-expressing cell, as shown by immu- 
nocytochemical staining with mAb F59 (Fig. 1). In contrast, 
the MHC-expressing cells of the BC3H-1 cell line were pre- 
dominantly mononucleated myocytes (Schubert et al., 1974) 
(Fig.  1), with a small number of myotubes that usually con- 
tained less than five nuclei.  Though BC3H-1  was the only 
cell line to form predominantly mononucleated myocytes, 
such  differentiated  mononucleated  ceils  were  formed  to 
some extent in cultures of each of the cell lines examined 
(Fig.  1).  Mononucleated myocytes were particularly abun- 
Figure 2. Immunoblot analysis of MHC expression by C2C12 myo- 
tubes. MHCs were prepared from adult mouse quadriceps (Quad), 
adult mouse soleus (Sol), and C2C12 myotubes (C2) formed after 
7 d in differentiation medium. MHCs were analyzed by SDS-PAGE 
in 5 % gels and intmunoblotting with mAbs $58, $46, $22, RIID10, 
and F59 as indicated. The mAbs specific for the slow MHC isoform 
expressed in the adult mouse soleus (Table II) also reacted with 
MHC expressed by C2C12 myotubes. 
Figure 3. Immunoblot analysis of MHC expression in differentiated 
cultures of mouse muscle cell lines. Aza2, BC3H-I, C2Cm TD33, 
and  TG1  cells  were  cultured  in  growth  medium  until  nearly 
confluent and then  incubated  for a further 7 d in differentiation 
medium.  As indicated,  MHCs were prepared from adult mouse 
quadriceps  muscle,  adult mouse soleus muscle, and the differen- 
tiated cultures, and analyzed by SDS-PAGE in 5 % gels and immu- 
noblotting with mAbs $58 and F59. MHC from BC3H-I cultures 
was also analyzed with mAb RllDl0. Differentiated cells of each 
cell line, except BC3H-1, expressed MHC that reacted with the slow 
MHC-specific mAb $58. A small amount of  MHC that reacted with 
mAb RllD10  was detected in BC3H-1 cultures. 
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expression in differentiated cultures of mouse muscle cell lines. 
Aza2,  BC3H-1, C2Ct2, TD33,  and  TG1  calls  were  cultured  in 
growth medium until near confluence and then incubated for a fur- 
ther 7 d in differentiation medium. MHCs were prepared from El5 
mouse limb, I>2 mouse limb, adult mouse quadriceps muscle, adult 
mouse  soleus muscle,  and  the  differentiated cultures,  and  the 
MHCs were analyzed by SDS-PAGE  in 5% gels and immunoblot- 
ting with mAbs F47 and F59 as indicated. Differentiated cells of 
each cell line, except BC3H-I, expressed MHC that reacted with 
mAb F47. 
Figure 4. Comparison of slow MHC expressed by the mouse and 
by mouse muscle cell lines. One-dimensional immunopeptide map- 
ping was used to compare MHCs prepared from adult mouse soleus 
muscle and from differentiated cultures of the C2C~z, Aza2, and 
TD33 cell lines, MHCs were partially proteolyzed as described in 
Materials and Methods,  and the resulting MHC fragments were 
analyzed by SDS-PAGE in 15% gels and by immunoblotting with 
mAb R11DI0  and an alkaline phosphatase-linked detection system. 
Samples were analyzed on adjacent lanes of  the same gel; color de- 
velopment took less time for the soleus than the cell culture MHCs. 
Slow MHCs from the soleus and differentiated cultures produced 
identical patterns of immunoreactive peptides. 
dant in cultures of the Aza2 and TG1 cell lines, accounting 
for up to 50 % of the nuclei in differentiated, MHC-express- 
ing cells formed by these two lines after 7 d in differentiation 
medium. In contrast, mononucleated myocytes usually ac- 
counted for <5 % of the MHC-expressing cells in cultures of 
CzCtz, TD33, TD38, and TD45 cells after 7 d  in differen- 
tiation medium.  Each of the cell lines,  particularly those 
generated by transfection, tended to have a lower differentia- 
tion index after repeated passage and thus accumulated less 
MHC. The patterns ofMHC isoform expression reported be- 
low were the same in cells of early and late passage (not 
shown). 
Expression of Slow MHC Protein 
Immunoblotting  analysis  suggested that  myotubes formed 
from C2C~2 cells expressed the slow MHC isoform. A sin- 
gle slow MHC isoform (alternatively known as the slow skel- 
etal or/3-cardiac MHC) is expressed at different stages of de- 
velopment in skeletal and heart muscle (Lompr6 et al., 1981, 
1984).  Myotubes  formed  from  C2C~2 cells  after  7  d  in 
differentiation medium  expressed MHC  that reacted with 
mAbs $58, $46, $22, and RllD10 (Fig. 2, lane 3). Each of 
these mAbs appeared to react with the slow skeletal//~-car- 
diac MHC found in the adult soleus (Fig. 2, lane 2), but did 
not react with the MHC(s) (predominantly Type liB) found 
in the adult quadriceps (Fig. 2, lane 1). Each of these mAbs 
also reacted with the slow skeletal//~-cardiac MHC isoform 
when it was expressed in the postnatal day 2 (P2) mouse ven- 
tricle, but did not react with the electrophoretically distinct 
a-cardiac MHC isoform that was coexpressed in the P2 ven- 
tricle (Lompr6 et al., 1981) (Table I]). Three additional slow 
MHC-specific mAbs, NOQT.5.4D, NA7, and NA8, (Narusawa 
et al., 1987; Bandman et al., 1990) also reacted with the slow 
MHC expressed in the soleus and in C2C~2 myotubes, but 
did not react with quadriceps MHC (not shown). Slow MHC 
from cultured cells and from the mouse had indistinguish- 
able electrophoretic mobilities.  The immunoblot band re- 
sulting from the reaction of mAb F59 with C2C~ MHC sam- 
ples was consistently wider than the $58 reaction band (Fig. 
2) or was a doublet (cf., Fig. 3), suggesting that, as in previ- 
ous work (Silberstein et al.,  1986; Weydert et al.,  1987), 
C2C12 myotubes expressed more than one MHC isoform (see 
below). 
Slow  MHC  expression was  not limited to  C2Ct~ cells. 
Cells  of the Aza2,  BC3H-1,  TD33,  TD38, and TG1  lines 
were cultured in low mitogen medium for 7 d, and the MHCs 
expressed were analyzed by SDS-PAGE in 5 % gels and im- 
munoblotting with mAbs $58 and F59  (Fig.  3).  Differen- 
tiated cells of  each line, except  BC3H-1, expressed MHC that 
reacted with mAb $58 (Fig. 3), as well as with mAbs $46, 
$22, NOQ7.5.4.D, NA7, NA8, and RllD10 (not shown). In 
four experiments  with BC3H-1  cells,  no detectable  slow 
MHC expression was found by immunoblotting with rnAbs 
$58, $46, and $22, whereas in each of the four experiments, 
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were incubated for 7 d in differentiation medium and analyzed by double immunofluorescence with mAbs F47 and F59 or with mAbs 
R11D10 and F59. Binding ofmAb F59 was detected with a rhodamine-conjugated secondary antibody and binding of mAbs F47 and R11D10 
was detected  with fluorescein-conjugated  secondary  antibodies  (see Materials  and Methods).  Note that mononueleated  myocytes that 
reacted with mAbs F47 and RllD10 were found in Aza2 and C2C~2 cultures, as well as in BC3H-1 cultures. Arrows indicate BC3H-1 myo- 
cytes that reacted with mAb F59 but not with mAb RI1D10. Bar, 75/~m. 
a  barely detectable band  was  seen using  the  high affinity 
mAb R11D10 (Fig. 3). The reaction of mAb F59 with MHC 
samples from differentiated Aza2,  TD33,  TD38,  and TG1 
cells  consistently  resulted  in  double  immunoblot  bands, 
whereas BC3H-1 MHC produced a single band upon reac- 
tion  with  mAb F59  (Fig.  3).  The predominant MHC  ex- 
pressed  by  BC3H-1  myocytes appeared  to  be  embryonic 
MHC (cf.,  Taubman et al.,  1989)  because it reacted with 
mAb 59,  did not react with mAbs F47 or $58,  and had an 
electrophoretic mobility that was indistinguishable from em- 
bryonic MHC and was less rapid than the electrophoretic 
mobility of slow MHC on double immunoblots (not shown; 
Miller and Stockdale,  1986a; Schiaffino et al., 1988,  1989). 
Thus, differentiated cells of most lines, like C2C~2 myotubes, 
appeared to express multiple MHCs (see below),  whereas 
BC3H-1  myocytes appeared to  express  mostly embryonic 
MHC and a very small amount of slow MHC. 
The slow MHC expressed in cultures appeared identical 
to the slow MHC expressed in the mouse. The structures of 
the slow MHCs expressed in the animal and in cultures were 
compared using one-dimensional immunopeptide mapping 
with  mAb  RllD10.  MHCs  were  isolated  from  the  adult 
Figure  7.  Expression  of MyoD1 and  myogenin 
mRNAs in mouse muscle  cell lines.  Total RNA 
from Aza2, BC3H-1, C2Ct2, TD33, and TG1 ceils 
was prepared  from nearly  confluent  cultures  in 
growth medium (G), and from cultures after 3 d 
in differentiation medium  (D) as indicated.  The 
levels of MyoD1 and myogenin mRNAs in 10 #g 
of total RNA were analyzed in parallel Northern 
blots. All samples were analyzed on the same gel; 
some lanes were rearranged  for presentation. 
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ventricle also gave identical immunopeptide maps with rnAb 
R11D10 (not shown); this result was predicted from previous 
findings that a single slow skeletal//~-cardiac MHC isoform 
is  expressed  in  the  adult  soleus  and  developing  heart 
(Lompr6 et al., 1984). The immunopeptide mapping results 
suggested that the slow MHC expressed in the animal was 
identical to the MHC isoform that reacted with slow MHC- 
specific mAbs and was expressed in differentiated cultures 
of the mouse muscle cell lines. 
Figure 8.  Exogenous MyoD1 expression and differentiation of BD 
cells lines. The BD1, BD2, and BD10 lines were derived by trans- 
fection of BC3H-1 cells with a plasmid on which MyoD1 expression 
was  under  control  of the  /3-actin promoter (see  Materials  and 
Methods). (A) MyoD1 and myogenin mRNA expression were ana- 
lyzed by Northern blot analysis of total RNA prepared from nearly 
confluent cultures of C2C~2, BC3H-1, BD1, BD2, and BD10 cells 
in  growth  medium.  For each  cell  line,  MyoD1 and  myogenin 
mRNAs were analyzed in duplicate gels in the same experiment, 
but different cell lines were analyzed in different experiments. (B, 
left) Phase microscopy of a living culture showed that BD10 cells 
formed multinucleated myotubes, and immunofluorescence analy- 
sis of a parallel culture (right) using polyclonal rabbit anti-MyoD1 
and  a  fluorescein-conjugated  secondary  antibody  showed that 
MyoD1 protein was expressed and localized to the nucleus of BD10 
cells. Bar, (left) 100 #m; (right) 25 #m. (C) Immunoblotting with 
mAbs F59, F47, and $58 was used to analyze MHCs expressed in 
cultures of C2Cm BC3H-1, BD1, BD2, and BD10 cells after 7 d in 
differentiation medium. Equal amounts of total protein were ana- 
lyzed in each lane. 
soleus muscle and from differentiated cells formed by the 
C2Cm Aza2, and TD33 cell lines. Partial proteolytic frag- 
ments of the MHCs were prepared, separated by SDS-PAGE 
in  15%  gels,  and tested for reactivity with mAb  RllD10. 
MHCs from the soleus muscle and from the differentiated 
cultures produced identical patterns of MHC fragments that 
reacted with mAb RllD10 (Fig.  4).  An additional experi- 
Additional MHC  lsoform Expression 
Differentiated cultures of  each muscle cell line except BC3H-1 
expressed at least one MHC isoform, apparently the perina- 
tal MHC, in addition to the embryonic and slow MHC iso- 
forms. For these experiments, cells of the Aza2, BC3H-1, 
C2Cm TD33, and TG1 lines were allowed to differentiate in 
low mitogen medium for 7 d, and the MHCs expressed were 
analyzed by SDS-PAGE in 5 % gels and immunoblotting with 
mAbs F59 and F47 (Fig. 5). In four experiments, BC3H-1 
myocytes did not express detectable MHC that reacted with 
mAb F47, whereas differentiated cultures of the Aza2, C:Ct~, 
TD33, and TG1  lines did express MHC  that reacted with 
mAb F47 (Fig. 5). The electrophoretic mobility of the MHC 
that reacted with mAb  F47 corresponded to the upper or 
most slowly migrating of the bands that reacted with mAb 
F59. This result suggested that the differentiated cultures ex- 
pressed the perinatal MHC isoform which, as shown for rat 
MHCs (Carraro and Catani,  1983; Schialtino et al.,  1988, 
1989), has a less rapid electrophoretic mobility than the em- 
bryonic, IIB, or slow MHC isoforms. Perinatal MHC protein 
and mRNA expression has been found previously in C2Ct2 
myotubes (Silberstein et al.,  1986; Weydert et al.,  1987). 
Based on electrophoretic mobility and mAb reactivity, there- 
fore, the MHC(s) that reacted with mAb F47 and was ex- 
pressed by all cell lines except BC3H-1 was likely to have 
been predominantly the perinatal isoform, though additional 
F47-reactive MHCs (e.g., IIA or IIB) might also have been 
expressed. The expression patterns of slow MHC and F47- 
reactive MHC were not changed when cells of the different 
cell lines were cultured on untreated culture dishes rather 
than  on  gelatin-coated  dishes.  The  three  TD  cell  lines, 
TD33, TD38, and TD45 cells, formed myotubes with similar 
morphologies and MHC expression patterns. 
The MHCs recognized by mAbs F47 and RllD10 were ex- 
pressed in every differentiated cell of  each cell line examined 
except  BC3H-1.  Double  immunofluorescence analysis  of 
Aza2  and  C2C~2 cultures  that  had  been  in  differentiation 
medium for 7  d  showed that every differentiated cell that 
reacted  with  mAb  F59  also  reacted  with  mAbs  F47  and 
RllD10 (Fig. 6). This same pattern of rnAb reactivity was 
seen with TD33 myotubes. Though the intensity of staining 
varied among cells in a culture, these results suggested that 
each differentiated Aza2,  C2C~2, and TD33 cell, including 
mononucleated myocytes (Fig. 6), had initiated slow MHC 
and perinatal MHC (i.e., F47-reactive MHC) expression by 
7 d in differentiation medium. As expected from the immu- 
noblotting results, differentiated BC3H-1 myocytes did react 
with mAb F59 but did not react with mAb F47 (Fig. 6) or 
mAbs $58, $46, and $22 (not shown). Some BC3H-1 myo- 
cytes did react with mAb RllD10 (Fig. 6), a result that was 
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by mAb RllD10 immunoblotting of BC3H-1 MHC. In one 
survey by double immunofluorescence, 59 out of 174 (34%) 
of  the BC3H-I myocytes that reacted with mAb F59 also gave 
a detectable  reaction with mAb RllD10.  The MHC(s) ex- 
pressed by most of  the cell lines was not assembled into sar- 
comeres. After 7 d in differentiation medium, many of the 
C2C~2 myotubes contained striations (e.g.,  F47-stained myo- 
tube in Fig. 6),  whereas very few (<10%) of the differen- 
tiated Aza2 cells and none of the differentiated BC3H-1 and 
TD33 cells  contained  striations.  Striations  were detected 
with mAbs F47, F59, and R11D10, suggesting that each MHC 
isoform expressed was assembled into sarcomeres. 
MyoDl and Myogenin mRNA Expression 
MyoD1 mRNA was expressed by cells of  each line examined 
except BC3H-1 (Fig. 7).  Total RNA from Aza2, BC3H-1, 
C2C12, TD33, and TG1 cells was prepared  from confluent 
cultures in growth medium and from cultures 3 d after switch- 
ing to differentiation medium. At both stages of  culture, cells 
of each line except BC3H-I  expressed amounts of MyoD1 
mRNA that were detectable by this Northern blot analysis, 
though the amount of MyoD1 mRNA varied among the cell 
lines (Fig. 7).  For the Aza2,  C~Cj2, and TD33 cell lines, 
the amount of MyoD1 mRNA stayed constant or decreased 
upon differentiation, whereas in TG1 cells MyoD1 mRNA 
levels increased  upon  differentiation.  Previous  work  also 
showed that BC3H-1 cells do not express MyoD1 mRNA 
(Davis et al., 1987; Edmondson and Olson,  1989), and that 
1ff1"1/2 cells transfected with myogenin additionally express 
MyoD1 mRNA that increases in amount upon differentiation 
(Thayer et al.,  1989). 
Myogenin mRNA was expressed by cells of each line ex- 
amined,  including BC3H-1 cells.  Myogenin mRNA levels 
varied markedly among the different cell lines, and BC3H-1 
cells expressed the lowest levels of myogenin mRNA (Fig. 
7). As seen previously for BC3H-1, C2C~, and rat L6 cells 
(Wright et al., 1989; Edmondson and Olson, 1989), myoge- 
nin mRNA levels were found to be higher in differentiated 
cultures of Aza2, TD33, and TG1 cells than in growing cul- 
tures. After 3 d in differentiation medium, myogenin mRNA 
levels in all cell lines except TG1 were increased greatly com- 
pared to growing cells. Myogenin mRNA was expressed at 
a relatively high level in growing TG1 cells, due to expres- 
sion from the transfected pEMSV-myogenin, and this level 
increased slightly after 3 d in differentiation medium. 
The relative amounts of MyoD1 and myogenin mRNAs 
were  markedly  different  in  confluent  and  differentiating 
cells.  MyoD1 mRNA  was generally  as abundant or more 
abundant than myogenin mRNA in growing cells, whereas 
myogenin mRNA  was much more abundant than MyoD1 
mRNA after 3 d in differentiation medium (Fig. 7). The ex- 
ceptions were BC3H-1 cells, which did not express MyoD1, 
and TG1 cells, in which MyoD1 mRNA was much less abun- 
dant than myogenin mRNA at each stage of culture, but in- 
creased upon differentiation rather than decreased as in the 
other MyoDl-expressing cell lines. Cultures  in low serum 
medium contained both cells that expressed MHC and cells 
that did not express MHC (Fig. 1); and the relative contribu- 
tions of the differentiated and undifferentiated cells to the 
changes  in  MyoD1 and myogenin mRNA  levels  seen  in 
differentiated cultures  remains to be determined.  Because 
myogenin mRNA levels are known to increase in BC3H-1, 
C2Cj2, and rat L6 cells during the first 2-3 d in differentia- 
tion medium and then decrease as incubation is prolonged 
(Wright et al.,  1989; Edmondson  and Olson,  1989), it is 
likely  that  the  relative  levels  of MyoD1 and  myogenin 
mRNAs in Aza2, TD33, and "I"(31 also will vary with time 
of incubation in culture. 
When exogenous MyoD1 was expressed in BC3H-1 cells, 
the morphology of the differentiated cells, but not the MHC 
expression pattern,  was changed. BC3H-1 cells were trans- 
fected with MyoD1 eDNA under control of the/3-actin pro- 
moter; and lines that were independently derived from dif- 
ferent transfections were cloned, expanded, and termed BD 
lines. The BD1, BD2, and BD10 cell lines, unlike the parent 
BC3H-1 line, expressed both MyoD1 mRNA (Fig. 8 A), and 
MyoD1 protein which was correctly localized to the nucleus 
(Fig. 8 B). Confluent cultures of  the BD cell lines in growth 
medium expressed much less MyoD1 mRNA than myogenin 
mRNA (Fig. 8 A). Unlike differentiated BC3H-1 cells, many 
of the differentiated BD1, BD2, and BD10 cells were multi- 
nucleated (Fig. 8 B), a result first found by Brennan et al. 
(1990). In one experiment, only 6% of  the nuclei in differen- 
tiated (i.e., F59-stained) BC3H-1 cells were in mnltinucle- 
ated myotubes (n = 450; 27 nuclei in myotubes, 423 nuclei 
in myocytes), whereas >90%  of the nuclei in differentiated 
BD10 cells were in multinucleated myotubes (n =  300; 271 
nuclei in myotubes, 29 nuclei in myocytes). In both BC3H-1 
and BD10 cultures, ~30% of  all nuclei were in differentiated 
cells after 7 d in differentiation medium. Immunoblot analy- 
sis with mAbs F59, F47, and $58 did not reveal any differ- 
ences in MHC expression between BD cell lines and the par- 
ent BC3H-1 cell line (Fig. 8 C). Differentiated BD cultures 
did not appear to accumulate as much striated muscle MHC 
per mg protein as BC3HA or C2C12 cultures (Fig. 8 A), but 
detectable MHC that reacted with $58 or F47 was not found 
even ila overloaded gels of BD myotube MHC (not shown). 
Thus, although BD cells expressed MyoD1 and formed mul- 
tinucleated myotubes, the BD myotubes expressed the same 
simple pattern  of MHCs as the parent  BC3H-1 myocytes, 
rather than the complex pattern of MHCs expressed by the 
morphologically similar myotubes formed by TD cell lines. 
Discussion 
Different types of mouse muscle cell lines were found to ex- 
press different patterns ofMHC isoforms, MyoD1, and myo- 
genin; but no correlation was found between the pattern of 
MHC isoform expression and the patterns  of MyoD1 and 
myogenin expression.  Differentiated cells  of most mouse 
myogenic cell lines expressed a complex pattern of MHCs, 
whereas  differentiated BC3H-1 and BD cells  expressed a 
simpler  pattern  of MHCs.  Different  myogenic cell  lines 
were,  therefore,  of multiple  types  that expressed  distinct 
myogenic programs  and  formed  myotubes  with  different 
MHC phenotypes. 
At least two MHC isoforms, slow MHC and F47-reactive 
MHC(s), were expressed in distinct patterns by the different 
cell lines. Slow MHC expression appeared to be quantita- 
tively different in different cell lines. Slow MHC was easily 
detected with mAbs $58, $46, and $22 in Aza2, C2Ct2, and 
TD myotubes, whereas,  in BC3H-1 myocytes, slow MHC 
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affinity mAb RllD10.  RllD10 has the same specificity for 
slow MHC as mAbs $58, $46, and $22, but has a binding 
constant  several  orders  of magnitude  greater  than  most 
mAbs (Khaw et al., 1984). On the other hand, F47-reactive 
MHC expression  may have been  qualitatively  different in 
different cell lines. No F47-reactive MHC was detectable in 
BC3H-1 myocytes or BD myotubes, whereas such MHC was 
easily detectable in myotubes formed by the other cell lines. 
Slow MHC was not previously known to be expressed by 
differentiated cells of mouse muscle cell lines. The identifi- 
cation of the slow skeletal//~-cardiac  MHC isoform was based 
on reaction with slow MHC-specific mAbs, electropboretic 
mobility,  and imrnunopeptide mapping.  By each  of these 
criteria,  the slow MHC expressed by cell lines was indistin- 
guishable from the slow MHC expressed in heart or soleus 
muscle  of the animal.  Because  seven slow MHC-specific 
rnAbs from four laboratories reacted with the slow MHC ex- 
pressed  by the cell lines,  it is unlikely that cross-reaction 
with MHC, other than slow MHC, was responsible for these 
results. 
The F47-reactive MHC expressed in differentiated Aza2, 
C2C~2, TD, and TG1 cultures appeared to be predominantly 
perinatal MHC because it had the same electrophoretic mo- 
bility and rnAb reactivity as perinatal  MHC. Because mAb 
F47 did not react with the embryonic and slow MHCs but 
did react with the perinatal, IIA, and liB MHCs, this mAb 
was a probe for MHCs that, in the animal, are expressed late 
in fetal and neonatal development, after the initial stages of 
myotube formation have occurred  (Narusawa et al.,  1987; 
Vivarelli et al.,  1988). The predominant  sarcomeric MHC 
expressed by differentiated BC3H-1 cells was probably the 
embryonic  MHC isoform (cf., Taubman et al.,  1989) be- 
cause it reacted with mAb F59, but not with mAbs F47 or 
$58, and it had the same mobility as embryonic MHC. Previ- 
ous  analyses  showed  that  C2C~2 myotubes  express  em- 
bryonic and perinatal MHC proteins, as well as embryonic, 
perinatal,  and IIB MHC mRNAs (Silberstein et al.,  1986; 
Weydert et al.,  1987). Further work will determine  if the 
MHC expression  patterns  change as myotubes formed by 
different lines mature in culture (Cerny and Bandman, 1986; 
Silberstein et al.,  1986; Weydert et al.,  1987; Miller and 
Stockdale,  1989). 
The complex pattern of MHC isoform expression was not 
dependent on the formation ofmultinucleated  myotubes. The 
mononucleated myocytes, as well as the myotubes, formed 
by Aza2,  C2Ct2, TD, and TG1  cells expressed slow MHC 
and F47-reactive MHCs, whereas the multinucleated myo- 
tubes formed by BD lines did not express detectable amounts 
of these MHCs. Additionally, exogenous MyoD1 expression 
in BC3H-1 cells did not lead to accumulation of slow and 
perinatal MHCs. BD cells expressed both MyoD1 and myo- 
genin, as did Aza2, C2C~2, TD, and TG1 cells, but BD myo- 
tubes did not express the complex pattern of  MHCs. Because 
the complex pattern of MHC expression was found in dif- 
ferent cell lines that expressed widely varying amounts of 
MyoD1 and myogenin mRNAs, no simple correspondence 
appeared to exist between the pattern of MHC isoform ex- 
pression and the patterns of  MyoD1 and myogenin  expression. 
This analysis did not determine if MyoD1 and myogenin 
expression might be necessary, though not sufficient, for a 
complex pattern  of MHC expression,  or if this pattern  of 
MHC expression  might be independent  of MyoD1. Myo- 
genic regulatory factors not examined here such as Myf-5, 
MRF4,MEF1,  and  MEF2  (Braun  et  al.,  1989a,  1989b; 
Buskin and Hauschka,  1989; Gossett et al., 1989; Mueller 
and Wold, 1989; Rhodes and Konieczny, 1989) might also 
play a role in differential MHC isoform expression.  These 
possibilities might be tested by using transfection and gene 
deletion to construct cell lines that express particular combi- 
nations  of regulatory  factors.  MyoD1 expression  did in- 
crease cell fusion and the formation of multinucleated myo- 
tubes in the BD lines (Brennan et al.,  1990), so the genes 
required for myoblast fusion may be among those that are 
transcriptionally regulated by MyoD1 (Braun et al., 1989a; 
Lin et al., 1989; Thayer et al., 1989). Additionally, because 
nuclei in BD myotubes would be expected to be postmitotic, 
MyoD1 expression may overcome the inability of BC3H-1 
cells to commit to terminal differentiation (Munson et al., 
1982; Spizz et al.,  1986; Taubman et al.,  1989). 
Several mechanisms might account for the different pat- 
terns ofMHC isoforms expressed by different cell lines. One 
possibility is that the slow and perinatal  MHC genes are no 
longer intact in the BC3H-1 and derived BD lines. It seems 
unlikely, however, that these two genes, which appear to be 
on different chromosomes (Mahdavi et al., 1984; Weydert et 
al.,  1985), would both  have mutated since  the origin  of 
BC3H-1 cells, whereas the embryonic MHC gene in BC3H-1 
cells and the embryonic, perinatal, and slow MHC genes in 
the CeCm2 and 10T1/2-derived cells would have remained in- 
tact. The small amount of slow MHC detected with mAb 
RllD10 in BC3H-1 myocytes also suggests that this gene is 
intact. Another possibility is that BC3H-1 and BD cells may 
be blocked at particular stages of a single myogenic differen- 
tiation pathway, much as different stages of the hematopoi- 
etic pathway are represented by cell lines that carry out only 
a portion of that developmental program. Alternatively, myo- 
blasts from different lines (e.g., BD and TD) might be com- 
mitted to form myotubes with distinct  MHC phenotypes. 
Multiple types of myoblasts have been identified at different 
stages of development in birds and mammals, and it seems 
likely that the different types of myoblasts  play distinct roles 
in the formation and diversification of primary and second- 
ary, fast and slow muscle fibers (White et al., 1975; Rutz and 
Hauschka,  1982; Miller  and  Stockdale,  1986a, 1986b, 
1989; Cossu and Molinaro, 1987; Vivarelli et al., 1988; Hoh 
et al., 1989). The different patterns of MHC isoform expres- 
sion in mouse myogenic cell lines may provide models for 
studying the intrinsic differences that distinguish the multi- 
ple types of myoblasts and myotubes found in developing 
animals. 
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